TechHx
The Human Experience of Health Technology
AI, medical devices, drug launches, and digital infrastructure reshaping care from hospital discharge to home. Coverage for the full continuum — not just the C-suite.
TechHx Coverage Areas
Nine technology domains shaping the human experience of care. From AI to devices to drugs to the university labs where they start.
Ambient AI & Documentation
AI scribes that capture patient-clinician interactions in real time are eliminating documentation burden in SNFs, home health agencies, and hospitals. The VA is deploying ambient AI to all medical centers in 2026.
Remote Patient Monitoring
Medicare updated RPM reimbursement coverage in 2026. Sensors, wearables, and virtual-ward platforms now routinely reduce 30-day readmissions by 20-28% across heart failure, COPD, and post-surgical populations.
AI-Driven Discharge Planning
A growing category of AI tools predicts discharge readiness, flags transition risks, and reduces ED boarding. Purpose-built for discharge planners — the audience most directly served by NewsHX.
Interoperability & Data Exchange
FHIR R4/R5, TEFCA, and USCDI+ are the backbone of value-based care contracts. When data doesn't flow across settings, outcomes suffer and contracts get clawed back. This is the infrastructure story of the decade.
Care Coordination Platforms
Agentic AI now automates multi-step coordination workflows including prior authorizations, referrals, and cross-setting scheduling. Integrated platforms are becoming essential infrastructure for the care continuum.
Medical Devices & Diagnostics
FDA 510(k) clearances and PMA approvals are accelerating. From continuous glucose monitors and smart implants to AI-powered imaging and point-of-care diagnostics, devices are moving faster through the regulatory pipeline than at any point in the last decade.
Drug Launches & FDA Approvals
Novel therapeutics, gene therapies, and biosimilars are reaching patients faster. For care teams managing complex patients across settings, understanding what's newly approved and how it changes protocols is essential — not optional.
Rehab & Recovery Tech
Exoskeletons, neurostimulation devices, AI-powered gait analysis, and digital physical therapy platforms are reshaping what recovery looks like in SNFs, IRFs, and the home. The post-acute setting is the fastest-growing frontier for recovery technology.
University Tech Transfer
Academic labs are where most breakthrough therapeutics and devices are born. Tech transfer offices license university IP to industry and spin out startups — the pipeline that turned mRNA research, CAR-T, and warfarin into medicine. Directory of major offices below.
Click any coverage area to filter the live news feed below.
TechHx Market Intelligence
Key data across AI, digital health, and technology adoption. Estimated figures from industry reports.
Annual spending ($M USD) · *2026 projected
Average % reduction by condition with remote monitoring
% of organizations with active deployment · Estimated
University Tech Transfer Directory
Where healthcare breakthroughs get licensed out of the lab. The major university and health-system technology transfer offices — the front door for licensing academic IP, partnering on research, and tracking the next wave of biotech and medtech spinouts.
One year of US academic tech transfer, end to end — AUTM FY2024 Licensing Survey
Licenses draw on the whole patent portfolio, not just the year's new grants — the pipeline compounds. A single year of disclosures seeds products for a decade.
The 1980 law that lets universities own — and commercialize — federally funded inventions
- 1
Federal grant funds the lab
NIH, NSF, and DoD dollars pay for the research that produces the invention.
- 2
University elects to own the invention
Under the Bayh-Dole Act (1980), the university — not the government — can take title. It must disclose the invention to the funding agency.
- 3
TTO protects and markets the IP
The tech transfer office files patents and shops the technology to industry partners.
- 4
License out — or spin out
Exclusive or non-exclusive licenses to established companies, or a new startup built around the IP (often with the university taking equity).
- 5
Royalties flow back
Inventors get a share by law; the rest funds more research and education.
- 6
Government keeps a backstop
A royalty-free license for federal use, plus rarely-used march-in rights if the invention isn't being made available.
Before Bayh-Dole (35 U.S.C. §§ 200–212), fewer than 5% of the government's ~28,000 patents had ever been licensed. The Act flipped ownership to universities — and built the modern biotech industry on top of it.
Penn Center for Innovation (PCI)
#1 in US gross licensing income (AUTM) — home of the CAR-T (Kymriah) and Karikó-Weissman mRNA/LNP patent estates.
Office of Technology Licensing (OTL)
The office that licensed the Cohen-Boyer recombinant-DNA patents — the deal that launched the biotech industry.
Technology Licensing Office (TLO)
Now under MIT's OSATT umbrella. Deep biotech spinout pipeline, from Moderna's roots to Editas-era gene editing.
Office of Technology Development (OTD)
Runs the Blavatnik Biomedical Accelerator; licensed foundational IP behind Editas and a long therapeutics roster.
Johns Hopkins Technology Ventures (JHTV)
Central commercialization hub for the top-funded US research university; FastForward incubator for biotech and medtech.
UC Innovation Transfer (systemwide + campus offices)
Largest US portfolio by volume across 10 campuses; second-largest licensing-income contributor after Penn.
Wisconsin Alumni Research Foundation (WARF)
The original tech transfer foundation (1925) — warfarin and vitamin D royalties built the model everyone else copied.
Columbia Technology Ventures (CTV)
The Axel co-transformation patents were among the highest-grossing university patents in history.
Office for Translation & Commercialization (OTC)
Rebranded from the Office of Licensing & Ventures; tight coupling with Duke Health for clinical-stage spinouts.
Innovation Partnerships
Reorganized from the Office of Technology Transfer in 2021; record commercialization-agreement volume since.
Mayo Clinic Ventures
180+ companies created and thousands of technologies licensed from the largest integrated clinical practice in the US.
Cleveland Clinic Innovations (CCI)
25 years, 2,800+ issued patents, 107 startups; 2025 strategic collaboration with Khosla Ventures.
Office details verified July 2026 — several offices were recently renamed (Duke OTC, Michigan Innovation Partnerships).